Benzene's toxicity: A consolidated short review of human and animal studies by HA Khan

Human and Experimental Toxicology

Volumn 26, Issue 9, 2007, Pages 687-696

  Snyder, R ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Aplastic anemia; Benzene; Glutathione; Hydroquinone; Leukemia; Muconaldehyde; Muconic acid; Phenol

Indexed keywords

BENZENE; HYDROQUINONE; OXIDOREDUCTASE; PHENOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

APLASTIC ANEMIA; BONE MARROW CELL; DNA DAMAGE; GENETIC TOXICOLOGY; GLUTATHIONE METABOLISM; HUMAN; LEUKEMIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; TOXICITY;

ANIMALS; BENZENE; BIOTRANSFORMATION; BONE MARROW; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; DNA; DNA DAMAGE; ENVIRONMENTAL POLLUTANTS; GLUTATHIONE; HEMATOLOGIC NEOPLASMS; HUMANS; HYDROQUINONES; MUTAGENS; NAD(P)H DEHYDROGENASE (QUINONE); OXIDATIVE STRESS; PHENOL; RISK ASSESSMENT; TOXICITY TESTS;

ANIMALIA;

EID: 36348994255     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/0960327107083975     Document Type: Review

References (60)

1. Guzelian P. Editorial. Evidence-based toxicology: call for papers. Hum Exp Toxicol 2007; 26: 5-7.
2. 1. In Jollow DJ, Kocsis, JJ, Snyder R, Vainio H, eds. Biological reactive intermediates I: formation, toxicity, and inactivation. Plenum Press, 1977: 6-24.
3. Gillette JR Commentary. A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity. I. Correlation of changes in covalent binding of reactivity metabolites with changes in the incidence and severity of toxicity. Biochem Pharmacol 1974; 23: 2785-94.
4. Lutz WK, Schlatter C. Mechanism of the carcinogenic action of benzene: irreversible binding to rat liver DNA. Chem Biol Interact 1977; 18: 241-5.
5. Snyder R, Lee EW, Kocsis JJ. Binding of labeled benzene metabolites in mouse liver and bone marrow. Res Commun Chem Pathol Pharmacol 1978; 20: 191-4.
6. 5, microsomal epoxide hydrolase, and glutathione transferases: Evidence for an important role of microsomal epoxide hydrolase in the formation of hydroquinone. Toxicol Appl Pharmacol 1993; 122: 172-81.
7. 1] benzene. Biochem J 1953; 54: 231-8.
8. Jerina DM, Daly JW. Arene oxides: a new aspect of drug metabolism. Science 1974; 185: 573-82.
9. Oesch F. Purification and specificity of a human microsomal epoxide hydratase. Biochem J 1974; 139: 77-88.
10. Vogel K, Bentley P, Platt KL, Oesch F. Eat liver dihydrodiol dehydrogenase. J Biol Chem 1980; 255: 9621-5.
11. 14C]phenol. Biochem J 1953; 55: 337-40.
12. Andrews LS, Lee EW, Witmer CM, Kocsis, JJ, Snyder R. Effects of toluene on the metabolism, disposition and hemopoietic toxicity of 3H-benzene. Biochem Pharmacol 1977; 26: 293-300.
13. Sammett D, Lee EW, Kocsis JJ, Snyder R. Partial hepatectomy reduces both metabolism and toxicity of benzene. J Toxicol Environ Health 1979; 5: 785-92.
14. Eastmond DA, Smith MT, Irons RD. An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol Appl Pharmacol 1987; 91: 85-95.
15. Subrahmanyam W, O'Brien PJ. Peroxidase catalyzed oxygen activation by arylamine carcinogens and phenol. Chem Biol Interact 1985; 56: 185-99.
16. Subrahmanyam VV, McGirr LG, O'Brien PJ. Peroxidase/hydrogen peroxide- or bone marrow homogenate/hydrogen peroxide-mediated activation of phenol and binding to protein. Xenobiotica 1990; 20: 1369-78.
17. Subrahmanyam VV, Kolachana P, Smith MT. Hydroxylation of phenol to hydroquinone catalyzed by a human myeloperoxidase-superoxide complex: possible implications in benzene myelotoxicity. Free Rad Res Communs 1991; 15: 285-96.
18. Subrahmanyam VV, Kolachana P, Smith MT. Metabolism of hydroquinone by human myeloperoxidase: Mechanisms of stimulation by other phenolic compounds. Arch Biochem Biophys 1991; 286: 76-84.
19. Subrahmanyam VV, Doane-Setzer KL, Steinmetz KL, Ross D, Smith MT. Phenol-induced stimulation of hydroquinone bioactivation in mouse bone marrow in vivo: possible implications in benzene myelotoxicity. Toxicology 1990; 62: 107-16.
20. Subrahmanyam VV, Ross D, Eastmond DA, Smith MT. Potential role of free radicals in benzene-induced myelotoxicity and leukemia. Free Rad Biol 1991; 11: 495-515.
21. Boersma MG, Balvers WG, Boeren S, Vervoort J, Rietjens I. NADPH-cytochrome reductase catalyzed redox cycling of 1,4-benzoquinone hampered at physiological conditions, initiated at increased pH values. Biochem Pharmacol 1994; 47: 1949-55.
22. Brunmark A, Cadenas E. Reductive addition of glutathione to p-benzoquinone, 2-hydroxy-p-benzoquinone, p-benzoquinone epoxides. Effect of the hydroxyl- and glutathionyl substituents on p-benzoquinone autoxidation. Chem Biol Interact 1988; 68: 273-98.
23. Brunmark A, Cadenas E, Lind C, Segura-Aguilar J, Ernster L. DT-diaphorase-catalyzed two-electron reduction of quinine epoxides. Free Rad Biol Med 1987; 3: 181-8.
24. Giloni L, Takeshita M, Johnson F, Iden C, Grollman AP. Bleomycin-induced strand-scission of DNA. J Biol Chem 1981; 256: 8608-15.
25. Gutteridge JM, Rowley DA, Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of ironsalts. Biochem J 1981; 199: 263-5.
26. Montiero HP, Winterbourn CC. The superoxide-dependent transfer of iron from ferritin to transferrin and lactoferrin. Biochem J 1988; 256: 923-8.
27. Kalinowski DS, Richardson DR. Future toxicology-Iron chelators and differing modes of action and toxicity: the changing face of iron chelation therapy. Chem Res Toxicol 2007; 20: 715-20.
28. Rao GS, Goel SK, Pandya KP. Accumulation of bleomycin sensitive iron and spontaneous oxygen radical generation by bone marrow cells of rats exposed to benzene. Clin Chem Enzym Comms 1990; 3: 313-8.
29. Singh V, Ahmad S, Rao GS. Prooxidant and antioxidant proprties of iron-hydroquinone and iron-1,2,4-benzenetriol complex. Implications for benzene toxicity. Toxicology 1994; 89: 25-33.
30. Ahmad S, Singh V, Rao GS. Release of iron from ferritin by 1,2,4-benzenetriol. Chem Riol Interact 1995; 96: 103-11.
31. Sabourin PJ, Bechtold WE, Henderson RF. A high pressure liquid chromatographic method for the separation and quantitation of water soluble radiolabeled benzene metabolites. Anal Biochem 1988; 17: 316-27.
32. Sabourin PJ, Bechtold WE, Birnbaum LS, Lucier, G, Henderson RF. Differences in the metabolism and disposition of inhaled [3H]benzene by F344/N rats and B6C3F1 mice. Toxicol Appl Pharmacol 1988; 94: 128-40.
33. Nerland DE, Pierce WM Jr. Identification of N-acetyl-S-(2, 5dihydroxyphenyl)-L-cysteine as a urinary metabolite of benzene, phenol, and hydroquinone. Drug Metab Dispos 1990; 18: 958-61.
34. Lau SS, Hill BA, Highet RJ, Monks TJ. Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increase glutathione substitution. Mol Pharmacol 1988; 34: 829-36.
35. Bratton SB, Lau SS, Monks TJ. Identification of quinol thioethers in bone marrow of hydroquinone/phenol-treated rats and mice and their potential role in benzene-mediated hematoxicity. Chem Res Toxicol 1997; 10: 859-65.
36. 59Fe incorporation into circulating erythrocytes. Toxicol Appl Pharmacol 1974; 27: 431-6.
37. Bratton SB, Lau SS, Monks TJ. The putative benzene metabolite 2,3,5-tris(glutationS-yl)hydroquinone depletes glutathione, stimulates sphingomyelin turnover, and induces apoptosis in HL-60 cells. Chem Res Toxicol 2000; 13: 550-6.
38. Tunek A, Platt KL, Przybylski M, Oesch F. Multi-step metabolic activation of benzene. Effect of superoxide dismutase on covalent binding of microsomal macromolecules, and identification of glutathione conjugates using high pressure liquid chromatography and field desorption mass spectrometry. Chem Biol Interact 1980; 33: 1-17.
39. Smart RC, Zannoni VG. DT-diaphorase and peroxide influence the covalent binding of the metabolites of phenol, the major metabolite of benzene. Mol Pharmacol 1984; 26: 105-11.
40. Smart RC, Zannoni VG. Effects of ascorbate on covalent binding of benzene and phenol metabolites to isolated tissue preparations. Toxicol Appl Pharmacol 1985; 77: 334-43
41. Ross D, Siegel D, Gibson NW, Pacheco D, Thomas DJ, Reasor TM, Wierda D. Activation and deactivation of quinones catalyzed by DT-diaphorase. Evidence for bioreactive activation of diaziquinone (AZQ) in human tumor cells and detoxification of benzene metabolites in bone marrow stroma. Free Radic Res Commun 1990; 8: 373-81.
42. Wermuth, B, Platt, KL, Seidel A, Oesch F. Carbonyl reductase provides the enzymatic basis of quinone detoxication in man. Biochem Pharmacol 1986; 35: 1277-82.
43. Siegel D, Ryder J, Ross D. NAD(P)H: quinone ooxidoreductase 1 expression in human bone marrow endothelial cells. Toxicol Lett 2001; 125: 93-8.
44. Siegel D, Gustafson L, Dehn DL, Han JY, Boonchoong P, Berliner LJ, Ross D. NAD(P)H: quinone oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol 2004; 65: 1238-47.
45. Ross D, Traver RD, Siege D, Misra V, Rauth AM. A polymorphis, in NAD(P)H:quinine oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity. Br J Cancer 1996; 74: 995-6.
46. Rothman N, Smith MT, Hayes RB, Traver RD, Hoener B, Campleman S, Li GL, Dosemeci M, Linet M, Zhang L, Xi L, Wacholder S, Lu W, Meyer KB, Titenko-Holland N, Stewart JT, Yin S, Ross D. Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C-T mutation and rapid fractional excretion of chloroxazone. Cancer Res 1997; 57: 2839-42.
47. Drummond JC, Finar IL. Muconic acid as a metabolic product of benzene, XV. Biochem J 1938; 32: 79-84.
48. Parke DV, Williams RT. The metabolism of benzene. The nature and amount of the muconic acid in benzene urine. Biochem J 1951; 49: xlix-lxiii.
49. Goldstein BD, Witz G, Javid J, Amoruso M, Rossman T, Wolder B. Muconaldehyde, a potential toxic intermediates of benzene metabolism. In Snyder R, Parke DV, Kocsis JJ, Jollow DJ, Gibson GG, Witmer CM eds. Biological reactive intermediates II. Plenum Press, 1982: 331-9.
50. Latriano L, Goldstein BD, Witz G. Formation of muconaldehyde, an open-ring metabolite of benzene, in mouse liver microsomes: An additional pathway for toxic metabolites. Proc Natl Acad Sci 1986; 83: 8356-60.
51. Grotz VL, Ji S, Goldstein BD, Witz G. Metabolism of benzene and trans, trans-muconaldehyde in the isolated perfused rat liver. Toxicol Lett 1994; 70: 281-90.
52. Goon D, Cheng X, Ruth JA, Petersen DR, Ross D. Metabolism of trans, trans-muconaldehyde by aldehyde and alcohol dehydrogenases: identification of a novel metabolite. Toxicol Appl Pharmacol 1992; 114: 147-55.
53. Zhang Z, Kline SA, Kirley TA, Goldstein BD, Witz G. Pathways of trans, trans-muconaldehyde metabolism in mouse liver cytosol: reversibility of monoreductive metabolism and formation of end products. Arch Toxicol 1993; 67: 461-7.
54. Kirley TA, Goldstein BD, Maniara WM, Witz G. Metabolism of trans, trans-muconaldehyde, a microsomal hematotoxic metabolite of benzene, by purified yeast aldehyde dehydrogenase and a mouse liver soluble fraction. Toxicol Appl Pharmacol 1989; 100: 360-7.
55. Kline SA, Robertson JF, Grotz VL, Goldstein BD, Witz G. Identification of 6-hydroxy-trans, trans-2,4-hexadienoic acid, a novel ring-opened urinary metabolite of benzene. Environ Health Perspect 1993; 101: 310-2.
56. Witz G, Rao GS, Goldstein BD. Short-term toxicity of trans, trans-muconaldehyde. Toxicol Appl Pharmacol 1985; 80: 511-6.
57. Guy RL, Dimitriadis EA, Hu PD, Cooper KR, Snyder R. Interactive inhibition of erythroid 59Fe utilization by benzene metabolites in female mice. Chem Biol Interact 1990; 74: 55-62.
58. Guy R.L, Hu P, Witz G, Goldstein BD, Snyder R. Depression of iron uptake into erythrocytes in mice by treatment with the combined benzene metabolites p-benzoquinone, muconaldehyde and hydroquinone. J Appl Toxicol 1991; 11: 443-6.
59. Snyder R, Hedli CC. An overview of benzene metabolism. Environ Health Perspect 1996; 104(Suppl 6): 1165-71.
60. Snyder R. Overview of the toxicology of benzene. J Toxicol Environ Health, Part A 2000; 61: 339-46.